Holdings (as at 2025-06-13)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.91%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2025-06-13)
Security Name % of Net Assets
ACADIA Pharmaceuticals Inc. 4.62%
Neurocrine Biosciences, Inc. 4.25%
Alnylam Pharmaceuticals, Inc. 4.02%
Genmab A/S (ADR) 3.76%
Exact Sciences Corporation 3.74%
Incyte Corporation 3.70%
Exelixis, Inc. 3.66%
BeOne Medicines Ltd. (ADR) 3.63%
Illumina, Inc. 3.61%
Biogen Inc. 3.52%
Natera, Inc. 3.47%
Mettler-Toledo International Inc. 3.44%
Alkermes Plc 3.43%
BioNTech SE (ADR) 3.43%
Gilead Sciences, Inc. 3.29%
Waters Corporation 3.27%
Repligen Corporation 3.22%
Amgen Inc. 3.20%
Corcept Therapeutics Inc. 3.17%
Moderna, Inc. 3.16%
United Therapeutics Corporation 3.13%
argenx SE (ADR) 3.09%
BioMarin Pharmaceutical Inc. 3.07%
Bruker Corporation 3.07%
Regeneron Pharmaceuticals, Inc. 2.96%
Vertex Pharmaceuticals Incorporated 2.92%
Halozyme Therapeutics, Inc. 2.78%
Krystal Biotech, Inc. 2.58%
Veracyte, Inc. 2.58%
Sarepta Therapeutics, Inc. 2.20%
Dreyfus Government Cash Management (Institutional Shares) 0.06%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.